Insights from 2023 ASH Annual Meeting
S

ASH 2023 Insights: "Early Benefits and Psychological Effects of Screening for MGUS - Results From the IstopMM Study"

By Insights from 2023 ASH Annual Meeting FEATURING Sæmundur Rögnvaldsson
By Insights from 2023 ASH Annual Meeting FEATURING Sæmundur Rögnvaldsson
59 views
December 29, 2023
0 Comments
Login to view comments. Click here to Login

Featured Video

13:04
Winship Cancer Institute - Emory University

Treatment-Related Quality of Life in MF

Feat. A. Hunter

Featured Video

06:51
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Prevalence and Prediction of Ruxolitinib Tr…

Feat. D. Tremblay

Related Content

AUTOPLAY
19:08
Insights from 2023 ASH Annual Meeting

ASH 2023 Summary: "Practice Changing Updates in MM, SMM and MGU…

Feat. R. Banerjee
41:54
University of Colorado Division of Hematology

Overview of Pathophysiology, Diagnosis and Management of Multiple My…

Feat. K. Sidor
10:23
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "iStopMM Study - Revised Definition of Free …

Feat. T. Einarsson Long
27:06
Moffitt Cancer Center

Hot Off the Press: Experts Discuss the Latest Data in Plasma Cell Dy…

Feat. R. Baz, M. Alsina, K. Shain, A. Grajales-Cruz
20:28
Dana-Farber Cancer Institute

The PROMISE of Early Detection and Interception in Myeloma

Feat. I. Ghobrial
26:58
Penn Medicine's 2024 Updates in Care of the Hematologic Malignancies Patient

2024 Updates on Myeloma Precursor Diseases and AL Amyloidosis

Feat. S. Susanibar-Adaniya
44:53
MyCancerHaven

Experts Discuss MGUS and Smoldering Myeloma

Feat. R. Vij, P. Kapoor
41:46
Yale Cancer Center

Early Detection and Interception in Myeloma: The PROMISE Study

Feat. I. Ghobrial
18:10
PrecisCa

Heme Tumor Board: 78 y/o Male With Newly Diagnosed Monoclonal Gammop…

Feat. D. Pollyea, A. Nooka, P. Forsberg, D. Schuster
23:42
GRACE

Multiple Myeloma & Cellular Therapies: A Patient-Centric Primer

Feat. S. Rajeeve
10:03
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "MGUS and the Risk of Thrombotic Events - Re…

Feat. S. Rögnvaldsson
22:16
SOHO Italy 1st School of Multiple Myeloma

Molecular Pathogenesis of MM: MGUS and SMM, Genomic Complexity of th…

Feat. N. Bolli
20:17
Indy Hematology Review

Therapy for Newly Diagnosed Myeloma - Role of Transplant and MRD, DA…

Feat. K. Anderson
54:04
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019

MGUS: Disease Definitions, Diagnostic Approaches and Risk Stratifica…

Feat. M. Gertz
22:20
SOHO Italy 1st School of Multiple Myeloma

Single-Cell Characterization of the BM Immune Microenvironment in MM…

Feat. C. Botta
19:12
SOHO Italy 1st School of Multiple Myeloma

1st/2nd Relapse in MM: Predictive Factors, EMD, Role of sFLC in MGUS…

Feat. U. Markovic
19:16
Memorial Sloan Kettering Cancer Center

Should Smoldering Myeloma Be Treated?

Feat. O. Landgren
16:11
Natalie Callander

MGUS: Risk Stratification and Therapeutic Options

16:38
SOHO Italy 1st School of Multiple Myeloma

Extracellular Vesicles in Myeloma: What Is Their Role in MGUS-to-MM …

Feat. A. Reale
13:27
Shaji Kumar

Evolving Concepts in the Diagnosis and Risk Stratification of Myeloma